Joseph B. Ciolino, MD
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Joseph B. Ciolino, MD sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Joseph B. Ciolino, MD: 4 sponsored US clinical trials, none currently recruiting.
Joseph B. Ciolino, MD sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. 1 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Other Autoimmune Diseases, with 1 trials.
Upper-quartile sponsor footprint
Joseph B. Ciolino, MD sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
A Randomized Clinical Trial of Ex Vivo Corneal Cross-Linking of Donor Keratoplasty Tissue for Keratoconus Used for Keratoplasty in Keratoconus Patients
NCT04584125
Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit
NCT02863809
Intraductal Meibomian Gland Probing Trial
NCT02256969
Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis
NCT01582880
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 4 | 1 |
How the Joseph B. Ciolino, MD early-phase archive is shaped
4 indexed studies, none listed as recruiting (0% open); 3 completed (75%).
Phase mix: 1 late (III/IV) vs 2 early (I/II) (early-phase heavy).
Top condition: Other Autoimmune Diseases (1 trial), 8 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Joseph B. Ciolino, MD: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Joseph B. Ciolino, MD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Joseph B. Ciolino, MD page
4 registered trials is a research-attention snapshot, not an endorsement of Joseph B. Ciolino, MD or any single study.
- None of Joseph B. Ciolino, MD's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Other Autoimmune Diseases is the condition Joseph B. Ciolino, MD studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Other Autoimmune Diseases trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Joseph B. Ciolino, MD pipeline card: 4 registered trials from official public datasets.Report a data error.